Modern R&D has its roots in experience from the past. On our way into the future we also looked back. In this way we discovered the heritage of modern invention: the technological principles of our inventions are essentially over 2000 years old.
AMW GmbH has specialised in the development and manufacturing of superior Drug Delivery Systems, appearing as Transdermal Therapeutic Systems (patches) und and biodegradable Implants, made to release the incorporated drugs over long time periods.
The advantages for patients are of particular importance to our engagement. These Drug Delivery Systems possess unique efficacy and comfort.
Long-term oral treatment of chronic diseases often causes irritation of the gastrointestinal tract. Consequently, patients perceive the continuous drug intake as detrimental to their quality of life. Blood level fluctuations, depending on the condition of the intestine and duration of intake, often lead to adverse effects, or reduce the therapeutic benefit of the drug substance. Some drugs are completely ineffective in the intestine upon oral intake. Such drugs have to be applied in a special way, i.e. transdermal, subcutaneously, intravenously, or pulmonary.
The aim of AMW is to provide therapeutic solutions in strongly growing indications such as
More than 25 customer and AMW projects have been started in these therapeutic areas, resulting in numerous national and international authorization procedures.
indication: moderate to severe pain
current status:pivotal clinical study
indication: diabetes, Diabetes, supportive treatment
current status: pilot study on healthy volunteers
Indikation:Diabetes, zur unterstützenden Behandlung
current status: pivotal clinical study
indication: Parkinson's disease, restless legs syndrome
Status:pivotale klinische Studie
indication: Alzheimer's disease
current status: application for marketing authorization in progress
for diverse indications